Chongqing Pharscin Pharmaceutical (002907.SZ) has completed the domestic production drug registration for three products.
Huarson Pharmaceuticals (002907.SZ) announcement, the company recently obtained information from the website of the China Food and Drug Administration that the company's...
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently obtained information from the website of the National Medical Products Administration that three of the company's products have completed the domestic production drug filing (application for drug instructions suitability for the elderly) and the filing information has been publicly posted on the website of the National Medical Products Administration. The related products are: Ba Wei Qi Long Granules, Teng Xie Ning Granules, and Gan Ju Bing Mei Pian.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


